McMillan Office’s Clorox CLX Stock Holding History

McMillan Office’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$927K	Hold	9,711	–	–	0.11%	86
2026 Q1	$1.01M	Sell	9,711 -1,000	-9%	-$113K	0.13%	80
2025 Q4	$1.08M	Buy	+10,711	New	+$1.16M	0.13%	78

Other funds holding CLX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

McMillan Office's CLX Position: Q2 2026 in Review

McMillan Office held its Clorox (CLX) position steady in Q2 2026 at 9,711 shares worth $927K. The position accounts for 0.11% of the portfolio, ranked #86.

McMillan Office first reported a position in CLX in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.08M in Q4 2025. 1,041 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

McMillan Office held 9,711 shares of Clorox worth $927K as of Q2 2026.
McMillan Office left its Clorox share count unchanged in Q2 2026.
Clorox made up 0.11% of McMillan Office's portfolio in Q2 2026, its #86 holding.
McMillan Office first reported a position in Clorox in Q4 2025 and has held it in 3 quarters since.
McMillan Office's Clorox position peaked at $1.08M in Q4 2025.
1,041 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on McMillan Office's 13F filing for Q2 2026, filed 13 Aug 2026.